Abstract: Disclosed is a tension delivery device for preventing urinary incontinence, which includes: Retzius space-insertion portions which are respectively to be inserted into the Retzius spaces positioned on the left side and right side of the urethra and move in response to the pressure or the Retzius spaces; and a urethral support portion which extends convergently from the Retzius space-insertion portions and serves to support the urethra upward, wherein the lateral cross section of the urethral support portion becomes thinner from Retzius space-insertion portions toward the distal end, and a mesh structure may be provided along the outer surface of the tension transfer device. The device can sufficiently inhibit urinary incontinence, and is minimally invasive so that damage associated with an invasive method can be reduced.

Abstract: Provided is an antihypertensive pharmaceutical composition containing Fimasartan, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as an angiotensin II receptor blocker, and Amlodipine, an isomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as a calcium channel blocker.

Abstract: Disclosed is a pressure-to-tension conversion device for treating urinary incontinence. The pressure-to-tension conversion device includes resilient sections which are inserted in and occupy Retzius spaces positioned in left and right sides of the urethra in front of the urinary bladder, respectively, and a support extending below the urethra and across the resilient sections in a “V” shape, wherein if the resilient sections are deformed as the abdominal pressure increases and the Retzius spaces contract, the support is tensioned, thereby supporting the urethra, so that the urinary incontinence can be treated. Consequently, the length of operation time for transplanting the pressure-to-tension conversion device can be shortened, a complication or a side effect can be reduced, and the charges of operation can be reduced. In addition, expensive operation materials can be substituted by the pressure-to-tension conversion apparatus, the costs for operation materials can be saved.

Abstract: Provided is an antihypertensive pharmaceutical composition containing Fimasartan, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as an angiotensin II receptor blocker, and Amlodipine, an isomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof or a hydrate thereof as a calcium channel blocker.

Abstract: Disclosed is a tension delivery device for preventing urinary incontinence, which includes: Retzius space-insertion portions which are respectively to be inserted into the Retzius spaces positioned on the left side and right side of the urethra and move in response to the pressure or the Retzius spaces; and a urethral support portion which extends convergently from the Retzius space-insertion portions and serves to support the urethra upward, wherein the lateral cross section of the urethral support portion becomes thinner from Retzius space-insertion portions toward the distal end, and a mesh structure may be provided along the outer surface of the tension transfer device.

Abstract: Disclosed is a pressure-to-tension conversion device for treating urinary incontinence. The pressure-to-tension conversion device includes resilient sections which are inserted in and occupy Retzius spaces positioned in left and right sides of the urethra in front of the urinary bladder, respectively, and a support extending below the urethra and across the resilient sections in a “V” shape, wherein if the resilient sections are deformed as the abdominal pressure increases and the Retzius spaces contract, the support is tensioned, thereby supporting the urethra, so that the urinary incontinence can be treated. Consequently, the length of operation time for transplanting the pressure-to-tension conversion device can be shortened, a complication or a side effect can be reduced, and the charges of operation can be reduced. In addition, expensive operation materials can be substituted by the pressure-to-tension conversion apparatus, the costs for operation materials can be saved.

Abstract: A plasma display panel includes first display electrodes and second display electrodes positioned inside barriers while opposing each other. A front panel has closed-type barriers to increase fluorescent substance application area. A rear panel has stripe-type barriers to lower address voltage between the first display electrodes and address electrodes and improve emission efficiency by means of long-gap discharge. The plasma display panel uses trigger discharge during address discharge and sustain discharge to lower discharge voltage.

Abstract: A plasma display panel includes a front and rear substrates separated from each other by a distance and defining a space therebetween to contain a discharge gas, a partition on the front substrate, the partition to separate the space into discharge cells, electrodes on the rear substrate, the electrodes to generate discharge in the discharge cells and a phosphor material in the discharge cells and on the front substrate.

Abstract: The present invention provides an apparatus for measuring flatness of a hot rolled strip based on a contact load of the hot rolled strip to split rolls of a looper in the hot rolling process. The split rolls are assembled in a bracket such that each split roll can be separated from the bracket. A normal-movement control unit for moving the split rolls in the normal direction, and a tangent-movement control unit for moving the split rolls in the tangent direction are porvided at a side of the bracket bearing the split rolls. An impact absorption unit is mounted at a support that is movably connected to the tangent-movement control unit. A pre-pressure application unit is provided at the support to prevent a sensor cap and a load sensor from being released. A heat-shielding ring surrounds the load sensor to prevent the load sensor from being overheated.